Emergent BioSolutions Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Joe Papa
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 1.2yrs |
Board average tenure | 3.4yrs |
Recent management updates
Recent updates
New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Emergent doses first participant in Phase 1 trial for Lassa virus vaccine
Sep 06Emergent BioSolutions: Now Long Through Sale Of October Put Spreads
Aug 24A Look At The Fair Value Of Emergent BioSolutions Inc. (NYSE:EBS)
Aug 13Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant
Aug 12Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss
Aug 01Moderna 2.0: 3 Stocks To Play The Potential Monkeypox Pandemic
Jul 26Emergent BioSolutions (NYSE:EBS) Takes On Some Risk With Its Use Of Debt
Jul 26Kamada inks $11.4 M supply deal for chickenpox preventive antibody Varizig
Jul 06Emergent BioSolutions: A Top Pick For The Monkeypox Outbreak
May 29Emergent BioSolutions Inc. (NYSE:EBS) Shares Could Be 37% Below Their Intrinsic Value Estimate
May 12Emergent BioSolutions (NYSE:EBS) Has A Pretty Healthy Balance Sheet
Apr 24CEO
Joe Papa (67 yo)
less than a year
Tenure
Mr. Joseph C. Papa, Jr., also known as Joe, serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining in June 13, 2023. He serves as Chairman at SparingVision SAS since March 2023....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive VP | 6yrs | US$3.52m | 0.30% $ 403.2k | |
Executive VP of External Affairs | less than a year | US$2.92m | 0.33% $ 441.3k | |
CEO & President | less than a year | no data | no data | |
Vice President of Investor Relations | 17.8yrs | no data | no data | |
Executive Vice President of Global Quality and Ethics & Compliance | 1.9yrs | no data | 0.32% $ 419.0k | |
Senior VP & Chief Human Resource Officer | less than a year | no data | no data | |
Senior VP | less than a year | no data | no data | |
Senior VP of Science & Development | 1.2yrs | no data | no data | |
Senior Vice President of Products Business | 1.2yrs | no data | 0.048% $ 63.2k | |
Senior Vice President of Manufacturing & Bioservices | no data | no data | 0.067% $ 88.7k |
1.2yrs
Average Tenure
Experienced Management: EBS's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 17.8yrs | US$410.00k | 0.083% $ 110.0k | |
Independent Director | 19.2yrs | US$412.50k | 0.019% $ 24.7k | |
Independent Director | less than a year | no data | no data | |
Independent Director | 1.9yrs | US$446.25k | 0.0055% $ 7.3k | |
Independent Director | 3.4yrs | US$398.75k | 0.011% $ 14.7k | |
Independent Non-Executive Chairman | 19.6yrs | US$512.50k | 0.053% $ 70.9k | |
Independent Director | 7.3yrs | US$427.50k | 0.031% $ 41.0k | |
Independent Director | less than a year | no data | no data | |
Independent Director | 1.7yrs | US$416.58k | no data |
3.4yrs
Average Tenure
61yo
Average Age
Experienced Board: EBS's board of directors are considered experienced (3.4 years average tenure).